Loading Events
  • This event has passed.

All Events

Management of Relapsed/Refractory DLBCL

June 15, 2023 @ 6:00 pm - 9:00 pm

OUTLINE

  1. The DLBCL Patient Journey: a series of patient cases, highlighting key moments where decisions made affect the outcomes for those patients.
  2. Treating Relapsed/Refractory DLBCL in 2023: Patient Outcomes: The latest updates in treatment of Relapsed/Refractory DLBCL. What do the guidelines say in 2023? What does the future hold? The role played by cost in treatment decisions for DLBCL patients
  3. Bone Marrow Transplant in refractory lymphoma. Is this an option in our setting?

SPEAKER PROFILES:

Prof Malkit Riyat

Malkit Riyat is an Associate Professor in Haematology and Consultant Haematologist, he completed his MBChB from the University of Nairobi in 1978. He was awarded a World Health Organization (WHO) scholarship and went on to do his membership in haematology from The Royal Infirmary, Glasgow in 1987. He was appointed as a Fellow of the Royal College of Pathologists in Haematology in 1997. He was Conferred fellowship of the College of Pathologists East Central and Southern Africa in 2014. He obtained a Certificate of Competence in Malignant Lymphomas (CCL) in 2017 – 2018 from University of ULM, Germany.

Prof. Riyat has authored multiple publications in peer review journals as well as many abstracts and has served on the editorial board of multiple peer review journals. He has been instrumental in graduate medical education, developing the curricula for the clinical pathology residency program and served as the first program director when the residency was initially initiated at the Aga Khan University Hospital in Nairobi. In 2002 he successfully implemented and coordinated the GIPAP program in Kenya through which patients with CML, GIST and several other disorders get free access to glivec.

Areas of Interest

  • Malignant Lymphomas
  • Multiple Myeloma
  • Low grade lymphoproliferative disorders (CLL, follicular lymphomas, Mantle Zone lymphomas etc)
  • Chronic myeloid leukemia (CML)
  • Myeloproliferative neoplasms / Myelodysplastic syndromes (PRV, ET, PMF, CMML)
  • Deficiency anaemias
  • Sickle cell disease
  • Thrombotic and Hemostatic disorders

Dr Douglas Nyandika

Douglas Nyandika is a Senior Registrar in Internal Medicine at the Nairobi Hospital, and is currently a fellow in Medical Oncology at the University of Nairobi.

He holds a bachelor’s degree and master’s in Internal Medicine from the University of Nairobi.

His current interests are in both hematologic malignancies especially lymphomas and leukaemia’s. In the area of solid tumours, he is interested in cancers of the breast, GI cancers and lung cancers with integration of novel therapies in their management.

Dr Nyandika is fascinated by African writers like Chimamanda Ngozi, Akwaeke Emezi and Jennifer Nansubuga. Inspired by spiritual books by Paulo Coelho, Michael Singer, and Eckhart Tolle.

 

Dr Rohini Radia

Rohini Radia completed her medical degree and postgraduate sub-specialty training in the UK. She obtained her MBChB degree in 1999. She continued with postgraduate training and obtained the MRCP (UK) qualification in internal medicine in 2005. She was a Specialist Registrar in haematology on a 5 year training programme at University Hospitals Bristol NHS Trust and obtained FRCPath(Haem) in 2005.

During her haematology training and work as a consultant, she pursued an interest in malignant haematology and allogeneic transplantation. She has extensive experience in haematology with a special interest in myeloid malignancies and bone marrow transplantation, including 10 years at consultant level at The Russell Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust. Dr Radia is a Kenyan and is keen to contribute her clinical expertise where there is a huge unmet clinical need in the area of stem cell transplantation. In January 2023, she returned home and started as BMT Consultant at the The Nairobi West Hospital.

Her BMT experience spans all aspects of stem cell transplantation from patient and donor selection to appropriate selection of conditioning protocol, GVHD prophylaxis and post-transplant management of immune suppression, acute and chronic GVHD and late effects. She worked closely with the Anthony Nolan transplant registry. She was the lead consultant for myelodysplasia, GVHD and apheresis. Dr Radia carried out the first syngeneic stem cell transplant at Nottingham University Hospitals NHS Trust. Clinical research has been an interest she has consolidated by active participation in clinical trials.

Prof Nicholas Othieno-Abinya (Moderator)

Nicholas Anthony Othieno-Abinya is a Consultant Medical Oncologist at the Nairobi Hospital Cancer Centre. He was formerly Professor of Medicine at the University of Nairobi, Kenya, where he was the director of Medical Oncology Fellowship Program and also the head of Haematology/Oncology at the University of Nairobi and Kenyatta National Hospital, Nairobi. In 2009 and 2010 he was Head of Oncology at Aga Khan University Hospital, Nairobi.

He holds a Master’s degree in Internal Medicine of the University of Nairobi, completed fellowship in Medical Oncology at the Royal London Hospital (University of London) in 1992, and is a Fellow of the Royal College of Physicians of Edinburgh.

His research interests are in malignant haematology and breast cancer, in which he has published widely in peer-reviewed journals. He also has keen interest in molecular oncology. He has also authored a text book titled Drug Treatment of Haematologic Neoplasms. He has also co-authored cancer booklets, and has written chapters in several books. His latest book titled ‘Shadow in Perpetuity’ by Lambert Publishers was released in December 2019.

Dr. Othieno-Abinya is a member of American Society of Clinical Oncology (ASCO), and served in its International Affairs Committee from 2010-2012; Africa Organization for Research and Training in Cancer (AORTIC), having been Vice Chair for Eastern Africa and was a long time member of Council; and European Society for Medical Oncology (ESMO). He founded Kenya Society of Haematology and Oncology (KESHO), of which he was the first Chair, and is still its Patron. His outstanding academic achievements were profiled in the University of Nairobi magazine,’ Varsity Focus’ of September 2017.

Dr Wangulu Collins (Co-Moderator)

Wangulu Collins is a Consultant General Pathologist and Lecturer at the Department of Human Pathology, School of Medicine, Jomo Kenyatta University of Agriculture & Technology (JKUAT).

He holds an undergraduate degree in Medicine & Surgery, a Master’s Degree in Public Health (MPH) and Masters of Medicine (Human Pathology).

Dr Wangulu currently practice as a General Pathologist at the JKUAT Medical School Teaching Hospitals (Thika Level 5 Hospital & Mama Lucy Kibaki Hospital) and consult for private hospitals in Nairobi, Kenya. Career interests; Research, Teaching and Clinical Practice.

Webinar Recording

Dear Guest, this content is restricted to only KESHO Members.

CME Photos

Details

Date:
June 15, 2023
Time:
6:00 pm - 9:00 pm
, ,